SEC Form D private-offering filing

Strand Therapeutics Inc.

Name: Strand Therapeutics Inc. - new SEC Form D private-offering filing, Boston, MA
Published: 2026-03-17

A new SEC Form D private-offering notice from Boston, MA, a $120,099,940 filer-stated offering target in Biotech. The source filing is one click away.

Strand Therapeutics Inc. site↗ Verified via SEC Form D

Clinical-stage biotech using synthetic biology to develop programmable mRNA immunotherapies for cancer and autoimmune disease.

Filed 2026-03-17Filed to raise $120,099,940First money in 2025-05-23Raised so far $108,099,927HQ (as filed) Boston, MASector Biotech ✓Stage (inferred) LateCall status Late filing

Source linked the Form D on EDGAR↗Website verified strandtx.com↗Named in the filing 7 executives & directors

Open this row on the live feed →More new filings in Massachusetts →More Biotech filings →

This is a public SEC Form D private-offering notice, the filer's own statement to the SEC. Amounts are offering targets, not confirmed closes. Takeoff Radar pulls Form D nightly from EDGAR and links every filing to its source.